Back to News
Market Impact: 0.15
Semaglutide Market Forecast 2027–2032: Valuation to Hit USD 64.51 Billion as Diabetes and Weight Management Demand Expands, Reports Mordor Intelligence
Source: globenewswire.com
Healthcare & Biotech
The semaglutide market was valued at USD 31.97 billion in 2026 and is projected to grow from USD 36.1 billion in 2027 to USD 64.51 billion by 2032. The excerpt’s stated CAGR is truncated at “12.”, so the full rate cannot be determined.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
More News
- Kimberly-Clark closes its acquisition of Tylenol maker Kenvue. What to expect next
- RA Capital Management sells $9.13M in Lenz Therapeutics shares
- Karyopharm stock rating cut to neutral by Rodman on bankruptcy
- Bright Minds shares fall as BTIG cuts price target on clinical hold
- Amgen (AMGN) Bets on MariTide to Crack $120 Billion Obesity Market
- Vertex Pharma meets Q3 estimates, raises revenue guidance